Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers

NCT03431272 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped no longer interest / resources to start study

Conditions

Contact Lens Dry Eye

Interventions

DRUG: Lifitegrast

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]